Regulatory & Compliance Support for Federal Medical Contracts

The contract provides consulting support to ensure compliance with federal pharmaceutical regulations, particularly focusing on the Drug Supply Chain Security Act, Federal Acquisition Regulation and Defense Federal Acquisition Regulation Supplement, as well as reporting obligations tied to Defense Logistics Agency medical supply contracts. The work involves guiding contractors through complex regulatory frameworks to maintain alignment with federal standards, prevent compliance gaps, and facilitate accurate and timely reporting for medical supply chain operations under DLA oversight. This subcontract, classified under NAICS code 541618 for other scientific and technical consulting services, is issued under the Department of Defense and is intended to support DLA’s mission-critical medical logistics functions. Although specific performance locations and point of contact details are not provided, the contract is active and publicly accessible through DIBBS with associated award identifiers, indicating its operational status and relevance to defense supply chain integrity. The solicitation was posted in July 2026, signaling a forward-looking procurement geared toward maintaining regulatory compliance ahead of upcoming federal mandates.